Replay available

Cipher Pharmaceuticals Inc. (CPH) Q2 2026 Earnings Call

Cipher Pharmaceuticals Inc. (TSX: CPH) Q2 2026 earnings conference call, held 2026-08-12. Replay captured from the company's public earnings webcast.

Wed, August 12, 2026 at 8:30 AMendedReplay
Cipher Pharmaceuticals Inc. (CPH) Q2 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Craig Mull

Interim Chief Executive Officer

Ryan Mailling

Chief Financial Officer

Bryan Jacobs

President, U.S. Business

Replay transcript excerpt

Good morning ladies and gentlemen and thank you for standing by. Welcome to the Cipher Pharmaceuticals quarterly conference call for the company's second quarter 2026 financial results. At this time, all participants are in listen-only mode. Following today's presentations, instructions will be given for the question and answer session. If anyone needs assistance at any time during the You may press the star followed by the zero on your push button phone. As a reminder, this conference is being recorded today, Wednesday, August 12 of 2026. On behalf of the speakers that follow, listeners are cautioned that today's presentation and the responses to questions may contain forward-looking statements with an understanding of the safe harbor provisions of the Canadian Provincial Securities Laws. Forward-looking statements involve risk and uncertainties and undue reliance should not be placed on such statements. Certain material factors or assumptions are implied in making forward-looking statements and actual results may differ materially from those expressed or implied in such statements. For additional information about factors that could cause results to vary, please refer to the risk identified in the company's annual information form and other filings with Canadian regulatory authorities. Except as required by Canadian securities laws, the company does not undertake to update any forward-looking statements, such as statements speak only as of the date made. And now, I would like to turn the call over to Mr. Craig Mull, Interim Chief Executive Officer of the company. Please go ahead, Mr. Mull. Good morning, everyone, and thank you for joining us today. Before I begin, I would like to remind everyone that all figures discussed on today's call are expressed in U.S. dolla...

More from Cipher Pharmaceuticals Inc.